Protein engineering of a fibroblast growth factor-1 fusion protein with cell adhesive activity

Acta Biochimica et Biophysica Sinica

Volumn 41, Issue 10, 2009, Pages 852-857

  Jeon, Eunyi ^a   Kim, Hae Won ^b,c   Jang, Jun Hyeog ^a  

^a Inha University School of Medicine   (South Korea)

^b Dankook University   (South Korea)

^c Dankook University   (South Korea)

Author keywords

Bone; Extracellular matrix; Fibroblast growth factor 1; Fibronectin; Fusion protein

Indexed keywords

FIBROBLAST GROWTH FACTOR 1; MEMBRANE PROTEIN; PORCN PROTEIN, HUMAN;

ARTICLE; CELL ADHESION; CELL CYCLE; CELL DIFFERENTIATION; GENETICS; HUMAN; METHODOLOGY; PHYSIOLOGY; PROTEIN ENGINEERING; TUMOR CELL CULTURE;

CELL ADHESION; CELL CYCLE; CELL DIFFERENTIATION; FIBROBLAST GROWTH FACTOR 1; HUMANS; MEMBRANE PROTEINS; PROTEIN ENGINEERING; TUMOR CELLS, CULTURED;

EID: 70349593725     PISSN: 16729145     EISSN: 17457270     Source Type: Journal    
DOI: 10.1093/abbs/gmp076     Document Type: Article

References (14)

1. Ornitz DM and Itoh N. Fibroblast growth factors. Genome Biol 2001, 2: 3005.
2. Damsky CH. Extracellular matrix-integrin interactions in osteoblast function and tissue remodeling. Bone 1999, 25: 95-96.
3. de Arcangelis A and Georges-Labouesse E. Integrin and ECM functions: Roles in vertebrate development. Trends Genet 2000, 16: 389-395.
4. Hynes RO. Integrins: Versatility, modulation, and signaling in cell adhesion. Cell 1992, 69: 11-25.
5. Choquet D, Felsenfeld DP and Sheetz MP. Extracellular matrix rigidity causes strengthening of integrin-cyoskeleton linkages. Cell 1997, 88: 39-48.
6. Ruoslahti E and Pierschbacher MD. New perspectives in cell adhesion: RGD and integrins. Science 1987, 238: 491-497.
7. Aota S, Nomizu M and Yamada KM. The short amino acid sequence Pro-His-Ser-Arg-Asn in human fibronectin enhances cell-adhesion function. J Biol Chem 1994, 269: 24756-24761.
8. Almeida EA, Ilic D, Han Q, Hauck CR, Jin F, Kawakatsu H and Schlaepfer DD, et al. Matrix survival signaling: from fibronectin via focal adhesion kinase to c-Jun N-terminal kinase. J Cell Biol 2000, 149: 741-754.
9. Bottazzi ME, Zhu X, Bohmer RM and Assoian RK. Regulation of p21cip1 expression by growth factors and the extracellular matrix reveals a role for transient ERK activity in G1 phase. J Cell Biol 1999, 146: 1255-1264.
10. Jang JH, Ku Y, Chung CP and Heo SJ. Enhanced fibronectin-mediated cell adhesion of human osteoblast growth factor, FGF-2. Biotechnol Lett 2002, 24: 1659-1663.
11. Stuki U, Schmid J, Hammerle CF and Lang NP. Temporal and local appearance of alkaline phosphatase activity in early stages of guided bone regeneration. A descriptive histochemical study in humans. Clin Oral Implants Res 2001, 12: 121-127.
12. Zakrzewska M, Marcinkowska E and Wiedlocha A. FGF-1: from biology through engineering to potential medical applications. Crit Rev Clin Lab Sci 2008, 45: 91-135.
13. Ascarelli MH and Morrison JC. Use of fetal fibronectin in clinical practice. Obstet Gynecol Surv 1997, 52: S1-S12.
14. de Jong JS, van Diest PJ, van Valk P and Baak JP. Expression of growth factors, growth-inhibiting factors, and their receptors in invasive breast cancer. II: Correlations with proliferation and angiogenesis. J Pathol 1998, 184: 53-57.